Clinical trial · Interventional
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
POSTCARE-O: Survivorship Care for Women Living With Ovarian Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Depressive Symptoms | — | UNRESOLVED | — |
| Ovarian Neoplasm | Ovarian Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| POSTCare Survivorship transition process | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention group
- description
- Group received care Using POSTCare process
- interventionNames
- Behavioral: POSTCare Survivorship transition process
- type
- NO_INTERVENTION
- label
- Usual Care
- description
- Group received usual care
Primary outcomes (1)
- measure
- Quality of Life by FACT-O
- timeFrame
- 12 Weeks
- description
- Quality of life measured by Functional Assessment of Cancer Therapy - Ovarian instrument composite scorecomprised of physical, emotional, functional, social, and disease specific subscales. Scoring range 0 - 152; a higher score indicates better quality of life.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Stage 2-4 ovarian cancer * Treated with some combination of surgery, chemotherapy, biologics, maintenance therapy * Within 6 months of completion of initial treatment (continued maintenance therapy okay) * Able to provide consent in English or Spanish Exclusion Criteria: * Admission to hospice at the completion of treatment for ovary cancer
References
Publications (1)
- DERIVEDKvale E, Phillips F, Ghosh S, Lea J, Hoppenot C, Costales A, Sunde J, Badr H, Nwogu-Onyemkpa E, Saleem N, Ward R, Balasubramanian B. Survivorship Care for Women Living With Ovarian Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2024 Feb 9;13:e48069. doi: 10.2196/48069. PMID 38335019